Notwithstanding, whether alleviation of NLRP3 inflammasome and its upstream mechanisms in the SG operation could be used as a new therapeutic target for T2DM and its related comorbidities remains to be further explored and elucidated. Here, NLRP3 is linked to type 2 diabetes mellitus.